Pulmonx Corporation (LUNG)
NASDAQ · Healthcare
Pulmonx Corporation Shareholder Equity 2020–2025
Pulmonx Corporation annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Pulmonx Corporation shareholder equity as of December 31, 2025: 54.1M, a 36.93% decrease year-over-year.
- Pulmonx Corporation shareholder equity for 2025 were 54.1M, a 36.93% decrease from 2024.
- Pulmonx Corporation shareholder equity for 2024 were 85.8M, a 27.47% decrease from 2023.
- Pulmonx Corporation shareholder equity for 2023 were 118.3M, a 23.18% decrease from 2022.
- Pulmonx Corporation shareholder equity for 2022 were 154.0M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Pulmonx Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $54 |
| 2024 | $86 |
| 2023 | $118 |
| 2022 | $154 |
| 2021 | $193 |
| 2020 | $226 |
Pulmonx Corporation Shareholder Equity — FAQ
Pulmonx Corporation (LUNG) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LUNG's shareholder equity history?
The chart and table above show Pulmonx Corporation's shareholder equity by year and by quarter, including the growth rate.